Progression and challenge of therapeutic strategies in neovascular age-related macular degeneration
10.3760/cma.j.issn.1005-1015.2016.01.002
- VernacularTitle:新生血管性老年性黄斑变性药物治疗面临的挑战与未来的发展趋势
- Author:
Yujing BAI
;
Xiaoxin LI
- Publication Type:Journal Article
- Keywords:
Wet macular degeneration/drug therapy;
Wet macular degeneration/radiotherapy;
Choroidal neovascularization/drug therapy;
Choroidal neovascularization/radiotherapy;
Angiogenesis inhibitors/therapeutic use;
Antibodies,monoclonal/therapeutic use;
Therapy/trends;
Ed
- From:
Chinese Journal of Ocular Fundus Diseases
2016;32(1):3-7
- CountryChina
- Language:Chinese
-
Abstract:
Choroidal neovascularization (CNV) is the key characteristic of neovascular age-related macular degeneration (nAMD),and the effective therapy is intravitreal injection of anti vascular endothelial growth factor (VEGF) agents based on clinical and basic research.In the meantime the challenge is how to further improve the inhibiting effect for CNV and visual function of anti-VEGF treatment on nAMD.The new strategy and drug delivery devices for anti-VEGF treatment will optimize the clinical scheme.From bench to bedside,the research on targeted treatment of angiogenesis brings the bloom of nAMD medical therapy.
